An integrative view on the carotid artery alterations in metabolic syndrome

European Journal of Clinical Investigation

Volumn 42, Issue 5, 2012, Pages 496-502

  Wang, Zhi Hao ^a   Gong, Hui Ping ^a   Shang, Yuan Yuan ^a   Tang, Meng Xiong ^a   Fang, Ning Ning ^a   Jiang, Gui Hua ^a   Zhang, Yun ^a   Zhong, Ming ^a   Zhang, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Carotid alterations; Metabolic syndrome; Ultrasonography

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; AGE; AGED; AGING; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY ANOMALY; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELASTICITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84859705097     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02605.x     Document Type: Article

References (29)

1. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629-36.
2. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-9.
3. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-14.
4. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006;47:1093-100.
5. Dogan S, Plantinga Y, Dijk JM, van der Graaf Y, Grobbee DE, Bots ML et al. Manual B-mode versus automated radio-frequency carotid intima-media thickness measurements. J Am Soc Echocardiogr 2009;22:1137-44.
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
7. Grundy SM. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 2006;5:295-309.
8. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
10. Espeland MA, Craven TE, Riley WA, Corson J, Romont A, Furberg CD. Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group. Stroke 1996;27:480-5.
11. Sutton-Tyrrell K, Wolfson SK Jr, Thompson T, Kelsey SF. Measurement variability in duplex scan assessment of carotid atherosclerosis. Stroke 1992;23:215-20.
12. Mizuguchi Y, Tanaka H, Oishi Y, Miyoshi H, Emi S, Ishimoto T et al. Predictive value of associations between carotid arterial sclerosis and left ventricular diastolic dysfunction in patients with cardiovascular risk factors. J Am Soc Echocardiogr 2007;20:806-12.
13. Paini A, Boutouyrie P, Calvet D, Zidi M, Agabiti-Rosei E, Laurent S. Multiaxial mechanical characteristics of carotid plaque: analysis by multiarray echotracking system. Stroke 2007;38:117-23.
14. Ulger Z, Aydinok Y, Gurses D, Levent E, Ozyurek AR. Stiffness of the abdominal aorta in beta-thalassemia major patients related with body iron load. J Pediatr Hematol Oncol 2006;28:647-52.
15. Koskinen J, Kähönen M, Viikari JS, Taittonen L, Laitinen T, Rönnemaa T et al. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young Finns study. Circulation 2009;120:229-36.
16. Claridge MW, Bate GR, Hoskins PR, Adam DJ, Bradbury AW, Wilmink AB. Measurement of arterial stiffness in subjects with vascular disease: ARE vessel wall changes more sensitive than increase in intima-media thickness? Atherosclerosis 2009;205:477-80.
17. Leone N, Ducimetière P, Gariépy J, Courbon D, Tzourio C, Dartigues JF et al. Distension of the carotid artery and risk of coronary events: the three-city study. Arterioscler Thromb Vasc Biol 2008;28:1392-7.
18. Humbert M, Montani D, Perros F, Dorfmüller P, Adnot S, Eddahibi S. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascul Pharmacol 2008;49:113-8.
19. Eddahibi S, Guignabert C, Barlier-Mur AM, Dewachter L, Fadel E, Dartevelle P et al. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation 2006;113:1857-64.
20. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.
21. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-13.
22. Yang WI, Lee SH, Ko YG, Kang SM, Choi D, Ha JW et al. Relationship between paraoxonase-1 activity, carotid intima-media thickness and arterial stiffness in hypertensive patients. J Hum Hypertens 2010;24:492-4.
23. Muntner P, Krousel-Wood M, Hyre AD, Stanley E, Cushman WC, Cutler JA et al. Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines. Hypertension 2009;53:617-23.
24. Patel A, ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-40.
25. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301-10.
26. Nicholls SJ, Nissen SE. Strategies to promote HDL-C: an emerging therapeutic target. Eur Heart J 2005;26:853-5.
27. Kontush A, Chapman MJ. Antiatherogenic small, dense HDL--guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med 2006;3:144-53.
28. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 2009;119:351-7.
29. Ferrucci L, Furberg CD, Penninx BW, DiBari M, Williamson JD, Guralnik JM et al. Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 2001;104:1923-6.